Back to Trials
NCT04250857Recruiting

HeartStart FRx Defibrillator Event Registry

Philips Clinical & Medical Affairs Global

Start Date

11/4/2019

Completion Date

12/1/2027

Summary

This post market clinical follow-up study is a multi-center, non-randomized, unblinded, observational registry of the performance of the FRx Automated external defibrillator (AED) used in conjunction with electrodes with or without use of the infant/child key. The registry is focused only on on post-event data collection and does not prescribe any device usage. This registry has several safeguards in place to prevent against selections bias, including enrollment of all participants who have pads placed. This registry will evaluate the safety and verify the clinical performance of the device in relation to its claims, when used in accordance with the Device Manual.

Eligibility Criteria

Age Range: No minimum to No maximum

Inclusion Criteria: * Subjects accepted into the study must: have been suspected of a circulatory arrest for any cause * Have had HeartStart FRx AED with electrodes: HeartStart SMART PADS II applied to their body and powered up, regardless of whether a defibrillation shock was delivered Exclusion Criteria: * AED or pad use other than the HeartStart FRx AED with electrodes : HeartStart SMART PADS II * AED used for training purposes.

Interventions

DEVICE

HeartStart FRX

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

Sudden Cardiac Arrest

Locations

Philips

Monroeville, Pennsylvania 15146

United States